Reducose® 5%

The Natural Glucose Control Extract

A patented mulberry leaf extract standardised to 5% 1-deoxynojirimycin (DNJ), clinically studied to help lower blood sugar, insulin and glycated haemoglobin levels.

What is Reducose® Good For?

Reducose® works by slowing down the breakdown of carbohydrates in the small intestine. This helps to reduce post-meal glucose spikes and result in improved glucose management overall.

 

Reducose® supplementation may lead to:

  • Reduction in post-prandial blood glucose and insulin response by inhibiting the access of carbohydrate-degrading enzymes
  • Decrease in fasting plasma glucose and glycated haemoglobin (HbA1c) levels when used long-term (~12 weeks)
  • Reducing the risk of heart injury caused by sepsis by decreasing oxidative damage and inflammation (as demonstrated in animal models)

What is 1-Deoxynojirimycin (DNJ)?

DNJ is a natural glucose analogue found in mulberry leaves. It acts as a mild, reversible inhibitor of amylases and α-glucosidase, the enzymes that break down carbohydrates into glucose.

 

By slowing carbohydrate digestion, DNJ reduces the rate at which glucose enters the bloodstream, demonstrating a lowered rise in blood sugar and insulin after eating.

What is the Recommended Daily Dose of Reducose®?

Human clinical studies suggest that 200 mg of Reducose® (5% DNJ), taken before a carbohydrate-containing meal, significantly reduces post-prandial glucose and insulin response.

Things to Know

Extracted from

Morus alba L. (white mulberry leaf)

Technology

Patented extraction and enrichment of DNJ to 5%

Region

Traditionally used in Asia for blood sugar balance; now clinically validated for managing blood sugar levels

Data

Multiple peer-reviewed human trials confirming efficacy in post-prandial glucose control

Reducose® in Detail

Clinical Dose
Clinical Dose

200 mg (5% DNJ, equivalent to 10 mg active DNJ)

Source
Source

Mulberry leaves (Morus alba L.)

Technology
Technology

Patented process to standardise DNJ at 5% and ensure reproducible carbohydrate enzyme blocking activity.

Key Benefits
Key Benefits
  • Clinically reduces blood sugar and insulin spikes after meals
  • May results in reduced fasting glucose and HbA1c levels when used long term (~ 12  weeks)
  • Works without hypoglycaemia risk in healthy individuals
Data
Data

Multiple peer-reviewed human studies demonstrate significant reductions in post-prandial glucose and insulin

Your Questions About Reducose®

Reach us arrow_forward
Reducose® is a patented mulberry leaf extract standardised to 5% DNJ, clinically shown to reduce blood sugar spikes after meals.
It helps to manage post-meal blood glucose and insulin levels as a single dose and results in reduced glucose markers in the longer term.
Generic mulberry powders vary in DNJ content. Reducose® is patented, standardised to 5% DNJ, and clinically validated for reproducible results.
Reducose® is well tolerated. At higher doses, mild gastrointestinal effects (gas, bloating) may occur due to slowed carbohydrate breakdown.
Reducose® is not a substitute for medical treatment. Individuals taking diabetes medication should consult their healthcare professional before use, as medications might have to be adjusted when used due to blood glucose lowering effects.

Discover your formula of ingredients

No two people are the same. That’s why your formula is uniquely yours. We select the most effective ingredients based on your health data, lifestyle, and goals — ensuring your capsules are both efficient and safe.

References

The Science That Supports Us

Cognitive and Neurological Support

Cui, W. et al. (2023) ‘Effect of mulberry leaf or mulberry leaf extract on glycemic traits: A systematic review and meta-analysis’, Food & Function, 14(3), pp. 1277–1289. doi:10.1039/d2fo02645g. 

Mental Health

Riche, D.M. et al. (2017) ‘Impact of mulberry leaf extract on type 2 diabetes (Mul-DM): A randomized, placebo-controlled pilot study’, Complementary Therapies in Medicine, 32, pp. 105–108. doi:10.1016/j.ctim.2017.04.006.

Nerve Repair

Thaipitakwong, T. et al. (2020) ‘A randomized controlled study of dose-finding, efficacy, and safety of Mulberry leaves on glycemic profiles in obese persons with borderline diabetes’, Complementary Therapies in Medicine, 49, p. 102292. doi:10.1016/j.ctim.2019.102292. 

Immune System Support

Thondre, P.S. et al. (2021) ‘Mulberry leaf extract improves glycaemic response and insulaemic response to sucrose in healthy subjects: Results of a randomized, double blind, placebo-controlled study’, Nutrition & Metabolism, 18(1). doi:10.1186/s12986-021-00571-2.